Fool.com
The World's Greatest Investing Community
Results 1 - 10 of 1089 : 1 2 3 4 5 6 7 8 9 Next
With double-digit gains, how could you not?
Health-Care Reform Is Very Taxing
On the industries that keep us alive.
Behind the Business: 3 Questions for Vical
Vical provides key insights for shareholders and potential investors.
Tired of Waiting, Teva Advances
When all else fails, just follow the established pathway to approval.
All share buybacks are not created equal.
Abbott Makes All the Right Moves
You've got to know when to hold 'em and know when to fold 'em.
Merck Makes a Mark on Good Cholesterol
Can't profit from fighting bad lipoproteins? Start boosting the good ones.
5-Star Stocks Poised to Pop: Abbott Labs
Market-trouncing returns could be written in these five stars.
Drug companies shape up, and it shows in their margins.
Or are these just dead cats getting a little air time?
Legal Information © 1995 - 2009 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK